Suppr超能文献

启动子甲基化与睾丸生殖细胞肿瘤之间的关联：一项荟萃分析和队列研究

Association Between Promoter Methylation and Testicular Germ Cell Tumor: A Meta-analysis and a Cohort Study.

作者信息

Markulin Dora, Vojta Aleksandar, Samaržija Ivana, Gamulin Marija, Bečeheli Ivona, Jukić Irena, Maglov Čedomir, Zoldoš Vlatka, Fučić Aleksandra

机构信息

University of Zagreb, Faculty of Science, Department of Biology, Division of Molecular Biology, Zagreb, Croatia.

University Hospital Centre Zagreb, Department of Oncology, Zagreb, Croatia.

出版信息

Cancer Genomics Proteomics. 2017 Sep-Oct;14(5):363-372. doi: 10.21873/cgp.20046.

DOI:10.21873/cgp.20046
PMID:28871003
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5611522/
Abstract

BACKGROUND

The RAS association domain family protein 1a (RASSF1A) is a prominent tumor suppressor gene showing altered promoter methylation in testicular germ cell tumors (TGCT). RASSF1A promoter hypermethylation might represent an early event in TGCT tumorigenesis. We investigated whether the RASSF1A promoter methylation in peripheral blood of TGCT patients can be associated with testicular cancer risk.

MATERIALS AND METHODS

Following a meta-analysis, we performed a cohort study including 32 testicular cancer patients and 32 healthy controls. Promoter methylation of the RASSF1A and O-methylguanine-DNA-methyltransferase (MGMT) genes was analyzed using bisulfite pyrosequencing of DNA from peripheral blood.

RESULTS

Meta-analysis showed an odds ratio (OR) of 7.69 for RASSF1A promoter methylation as a risk factor for TGCT. Cohort study found altered methylation of the RASSF1A promoter in blood of TGCT patients. Methylation was higher in TGCT patients before BEP chemotherapy.

CONCLUSION

The meta-analysis indicates a role of the RASSF1A promoter hypermethylation from peripheral blood in TCGT. We confirmed that finding in our cohort study, which represents the first report of changed RASSF1A promoter methylation in peripheral blood TGCT.

摘要

背景

RAS 关联结构域家族蛋白 1a（RASSF1A）是一种重要的肿瘤抑制基因，在睾丸生殖细胞肿瘤（TGCT）中其启动子甲基化发生改变。RASSF1A 启动子高甲基化可能是 TGCT 肿瘤发生的早期事件。我们研究了 TGCT 患者外周血中 RASSF1A 启动子甲基化是否与睾丸癌风险相关。

材料与方法

在进行荟萃分析之后，我们开展了一项队列研究，纳入 32 例睾丸癌患者和 32 例健康对照。使用外周血 DNA 的亚硫酸氢盐焦磷酸测序分析 RASSF1A 和 O -甲基鸟嘌呤 - DNA -甲基转移酶（MGMT）基因的启动子甲基化情况。

结果

荟萃分析显示，RASSF1A 启动子甲基化作为 TGCT 的危险因素，其优势比（OR）为 7.69。队列研究发现 TGCT 患者血液中 RASSF1A 启动子甲基化发生改变。在接受 BEP 化疗前，TGCT 患者的甲基化水平更高。

结论

荟萃分析表明外周血中 RASSF1A 启动子高甲基化在 TCGT 中发挥作用。我们在队列研究中证实了这一发现，这是外周血 TGCT 中 RASSF1A 启动子甲基化改变的首次报道。

相似文献

1
Association Between Promoter Methylation and Testicular Germ Cell Tumor: A Meta-analysis and a Cohort Study.
Cancer Genomics Proteomics. 2017 Sep-Oct;14(5):363-372. doi: 10.21873/cgp.20046.
2
Aberrant epigenetic inactivation of RASSF1A and MGMT gene and genetic mutations of KRAS, cKIT and BRAF in Indian testicular germ cell tumours.
Cancer Genet. 2020 Feb;241:42-50. doi: 10.1016/j.cancergen.2019.10.002. Epub 2019 Oct 13.
3
DNA methylation profiling as a tool for testicular germ cell tumors subtyping.
Epigenomics. 2018 Dec;10(12):1511-1523. doi: 10.2217/epi-2018-0034. Epub 2018 Nov 12.
4
Frequent epigenetic inactivation of the RASSF1A tumour suppressor gene in testicular tumours and distinct methylation profiles of seminoma and nonseminoma testicular germ cell tumours.
Oncogene. 2003 Jan 23;22(3):461-6. doi: 10.1038/sj.onc.1206119.
5
Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells.
Oncol Rep. 2012 Apr;27(4):1135-41. doi: 10.3892/or.2012.1624. Epub 2012 Jan 9.
6
Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance.
Clin Cancer Res. 2008 May 1;14(9):2664-72. doi: 10.1158/1078-0432.CCR-07-1232.
7
Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.
Cell Biol Int. 2012 May 1;36(5):427-32. doi: 10.1042/CBI20100851.
8
Alteration in the expression of MGMT and RUNX3 due to non-CpG promoter methylation and their correlation with different risk factors in esophageal cancer patients.
Tumour Biol. 2017 May;39(5):1010428317701630. doi: 10.1177/1010428317701630.
9
Pyrosequencing assays to study promoter CpG site methylation of the O6-MGMT, hMLH1, p14ARF, p16INK4a, RASSF1A, and APC1A genes.
Oncol Rep. 2009 Mar;21(3):721-9.
10
Promoter hypermethylation of RASSF1A, MGMT, and HIC-1 genes in benign and malignant colorectal tumors.
Tumour Biol. 2011 Oct;32(5):845-52. doi: 10.1007/s13277-011-0156-7. Epub 2011 Jan 28.

引用本文的文献

1
A multi-analyte liquid biopsy approach for nonseminomatous testicular germ cell tumors: combining cfDNA and N-glycan analysis in blood and seminal plasma.
Cancer Cell Int. 2025 Jul 11;25(1):257. doi: 10.1186/s12935-025-03887-8.
2
Recent Advancements in Research on DNA Methylation and Testicular Germ Cell Tumors: Unveiling the Intricate Relationship.
Biomedicines. 2024 May 8;12(5):1041. doi: 10.3390/biomedicines12051041.
3
Epigenetic Factors and ncRNAs in Testicular Cancer.
Int J Mol Sci. 2023 Jul 30;24(15):12194. doi: 10.3390/ijms241512194.
4
Testicular Germ Cell Tumor Tissue Biomarker Analysis: A Comparison of Human Protein Atlas and Individual Testicular Germ Cell Tumor Component Immunohistochemistry.
Cells. 2023 Jul 13;12(14):1841. doi: 10.3390/cells12141841.
5
Epigenetic Regulation of Driver Genes in Testicular Tumorigenesis.
Int J Mol Sci. 2023 Feb 19;24(4):4148. doi: 10.3390/ijms24044148.
6
The utility of cfDNA in TGCT patient management: a systematic review.
Ther Adv Med Oncol. 2022 May 25;14:17588359221090365. doi: 10.1177/17588359221090365. eCollection 2022.
7
Epigenetics and Testicular Cancer: Bridging the Gap Between Fundamental Biology and Patient Care.
Front Cell Dev Biol. 2022 Apr 8;10:861995. doi: 10.3389/fcell.2022.861995. eCollection 2022.
8
GPER and Testicular Germ Cell Cancer.
Front Endocrinol (Lausanne). 2021 Jan 26;11:600404. doi: 10.3389/fendo.2020.600404. eCollection 2020.
9
Epigenetically inactivated RASSF1A as a tumor biomarker.
Bosn J Basic Med Sci. 2021 Aug 1;21(4):386-397. doi: 10.17305/bjbms.2020.5219.
10
Cisplatin Resistance in Testicular Germ Cell Tumors: Current Challenges from Various Perspectives.
Cancers (Basel). 2020 Jun 17;12(6):1601. doi: 10.3390/cancers12061601.

本文引用的文献

1
MGMT and CALCA promoter methylation are associated with poor prognosis in testicular germ cell tumor patients.
Oncotarget. 2016 Aug 10;8(31):50608-50617. doi: 10.18632/oncotarget.11167. eCollection 2017 Aug 1.
2
Identification of 19 new risk loci and potential regulatory mechanisms influencing susceptibility to testicular germ cell tumor.
Nat Genet. 2017 Jul;49(7):1133-1140. doi: 10.1038/ng.3896. Epub 2017 Jun 12.
3
The relationship between RASSF1A gene promoter methylation and the susceptibility and prognosis of melanoma: A meta-analysis and bioinformatics.
PLoS One. 2017 Feb 16;12(2):e0171676. doi: 10.1371/journal.pone.0171676. eCollection 2017.
4
Cancer Death Risk Related to Radiation Exposure from Computed Tomography Scanning Among Testicular Cancer Patients.
Anticancer Res. 2017 Feb;37(2):831-834. doi: 10.21873/anticanres.11385.
5
The World Health Organization 2016 classification of testicular germ cell tumours: a review and update from the International Society of Urological Pathology Testis Consultation Panel.
Histopathology. 2017 Feb;70(3):335-346. doi: 10.1111/his.13102. Epub 2016 Dec 14.
6
Outcome of Resection and Chemotherapy versus Chemotherapy Alone for Retroperitoneal Recurrence of Testicular Cancer Involving the Inferior Vena Cava: A Retrospective Cohort Study of 22 Consecutive Patients.
Anticancer Res. 2016 Jul;36(7):3483-8.
7
Aberrant Methylation of RASSF1A Closely Associated with HNSCC, a Meta-Analysis.
Sci Rep. 2016 Feb 9;6:20756. doi: 10.1038/srep20756.
8
Testicular germ cell tumours.
Lancet. 2016 Apr 23;387(10029):1762-74. doi: 10.1016/S0140-6736(15)00991-5. Epub 2015 Dec 3.
9
Epidemiology and Diagnosis of Testis Cancer.
Urol Clin North Am. 2015 Aug;42(3):269-75. doi: 10.1016/j.ucl.2015.04.001. Epub 2015 Jun 11.
10
Cancer Risk in Relatives of Testicular Cancer Patients by Histology Type and Age at Diagnosis: A Joint Study from Five Nordic Countries.
Eur Urol. 2015 Aug;68(2):283-9. doi: 10.1016/j.eururo.2014.12.031. Epub 2015 Apr 23.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验